News Focus
News Focus
Followers 41
Posts 22117
Boards Moderated 2
Alias Born 07/10/2015

Re: joev2 post# 41126

Friday, 05/24/2024 11:22:57 AM

Friday, May 24, 2024 11:22:57 AM

Post# of 42661
You've said alot without really saying anything. There is no indication of failure at Sintx anymore nor is there any indication they are not ready for success. Years ago it may have looked like failure was possible but thats no longer true. In regards to fear of success, i can see Sonny's been laying the foundation and is building toward something. What that something is exactly im not 100% sure. Using the OEM model, Sintx can license its IP without burdening itself in heavy investment which is why itll be much easier for them to succeed; very lean operation. These actions do not suggest fear of success. I dont see fear of success but instead waiting. Like waiting for Zimvie to sell spine and Solventum to complete its divestment from 3M. Things outside of Sintx are slowly coming together but im not entirely sure what the movements are meant for.
The only thing going on now is management has game changing products and is just sitting on them, waiting for whatever reason. Although sitting on them is not accurate description, but thats how it seems.
To be fiscally responsible means to manage financial resources well. Sintx does not take out high interest loans, it has no debt. It does not spend large amounts on excessive personnel and its facilities are minimal. Its cash burn is not bad considering the costs of R&D. Please go through their financials and show where there is alot of financial waste. You will not find it and no Sonny's salary is not waste nor overinflated.

I also disagree with you that they are handling things well fiscally as a company in r & d stage


Please Joe enlighten me on how they are not handling things well. To date your complaints have been almost entirely geared toward raising funds. I do agree its odd that Sonny will raise funds at lower stock prices instead of at more opportune times when things would be less dilutive. This could be connected to news. They tend to raise funds around positive news with little news in between.

SIntx already has a major stakeholder in Zimmer Biomet, it just does not own any shares YET. Because Zimmer Biomet and management do not really have shares, that allows this manipulation game to continue in regards to the stockprice. Theres a reason Zimmer's name was removed from Sintx IPO paperwork in 2013 but was there when the company tried to go public in 2007. That removal has played a part in why this manipulation game continues. I wonder if Zimmer wanted them to do that? Be interesting if Zimmer played a larger role in the manipulation of the stockprice.

Sintx - Zimmer connection purposefully not disclosed/removed from 2013 IPO paperwork?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174144294

Oh and Joe, why do you care about memes on ST unless you have an account there?

========================================

it actually means the massive issuance of dilutive new shares can continue.....


Where was this comment last year Atlanta? Shareholder rights offerings are the best protection against dilution but it looks like youre trying to play peoples fear. I suggest holding minimal shares so one can participate in rights offerings..multiplied by 200 to account for the RS. Best way to minimize risk while staying in the game until funds are done gaming this; otherwise keep watching because the tech is very valuable. First clue they are about done is Sonny stepping down. Next will be management buying shares.

========================================

A basic roadmap laid out of Zimmer's intentions for Sintx back in 2011. This quote predates Sintx vast IP portfolio expansion. Any markets Zimmer Biomet does not currently participate in, that Sintx does, represents potential markets Zimmer Biomet can utilize Sintx to bolster its revenue through licensing as well as diversify those revenue sources.

AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.


https://web.archive.org/web/20240408163612/https://spineblogger.blogspot.com/2011/05/whos-next.html?m=1

Silicon Nitride = Next Gen Hip implant material

Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics


https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/

Sintx - Zimmer Connection
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053353

Sintx - Biomet R&D
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053136

Dr. Pezzotti member of Sintx scientific board and his research for Biomet
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174052660

Zimmer Biomet Hires Si3N4 Coatings Expert for its anti-infective dvision - December 2018
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174115529

Zimmer Biomet pays 2.5m certain R&D payment Q2 2017, Dr Bal's investment company loans $2.5m to Sintx.Q3, 2017
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174152867

Sintx - Morgan Ceramics partnership & NP Aerospace Connections
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174166246
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174166439


Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'.


One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant


Could it be that there is a strategy to distract people away from looking at the basic data?
Is all this an exercise to create more and more forum verbiage to drown out any serious discussion of evidence?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SINT News